Holdings over time
(Since February 1, 2022)
Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
---|---|---|---|---|
ImmunoGen Inc (IMGN) | 4.23% | 0% | 72.41% | 2/14/2024 |
Eli Lilly (LLY) | 4.06% | 3.08% | 96.93% | - |
Bridgebio (BBIO) | 3.87% | 3.85% | 65.86% | - |
Vertex (VRTX) | 3.69% | 3.03% | 96.93% | - |
Merck (MRK) | 3.46% | 2.58% | 96.93% | - |
CRISPR Therapeutics (CRSP) | 3.43% | 2.77% | 96.93% | - |
Regeneron (REGN) | 3.4% | 2.77% | 96.93% | - |
Johnson & Johnson (JNJ) | 3.26% | 3.64% | 96.93% | - |
Amgen (AMGN) | 3.16% | 2.86% | 96.93% | - |
AbbVie (ABBV) | 3.16% | 3.15% | 96.93% | - |
Gilead Sciences (GILD) | 3.15% | 3.51% | 96.93% | - |
Bristol-Myers Squibb (BMY) | 3.07% | 3.59% | 96.93% | - |
Pfizer (PFE) | 2.91% | 2.81% | 96.93% | - |
Exact Sciences (EXAS) | 2.88% | 4.85% | 96.93% | - |
Illumina (ILMN) | 2.85% | 4.48% | 96.72% | - |
Guardant Health (GH) | 2.77% | 2.46% | 96.93% | - |
Iovance (IOVA) | 2.32% | 3.83% | 65.86% | - |
Blueprint Medicines (BPMC) | 2.19% | 2.59% | 65.86% | - |
Argenx (ARGX) | 2.15% | 3.56% | 65.86% | - |
Mirati Therapeutics Inc (MRTX) | 2.14% | 0% | 70.93% | 1/31/2024 |
Revolution Medicines (RVMD) | 2.12% | 3.78% | 65.86% | - |
Exelixis (EXEL) | 2.07% | 3.54% | 59.3% | - |
Syndax (SNDX) | 1.95% | 3.46% | 65.86% | - |
BeiGene (BGNE) | 1.87% | 0% | 67.86% | 1/2/2024 |
Fate Therapeutics (FATE) | 1.69% | 0% | 67.86% | 1/2/2024 |
Seagen Inc (SGEN) | 1.57% | 0% | 35.2% | 12/18/2023 |
Legend Biotech (LEGN) | 1.3% | 0% | 36.79% | 1/2/2024 |
Incyte (INCY) | 1.27% | 0% | 31.08% | 1/12/2023 |
BioNTech SE (BNTX) | 1.18% | 0% | 31.08% | 1/12/2023 |
2Seventy Bio (TSVT) | 1.18% | 0% | 31.08% | 1/12/2023 |
Crinetics (CRNX) | 1.16% | 3.99% | 29.07% | - |
Arcellx (ACLX) | 1.11% | 4.82% | 29.07% | - |
Agenus (AGEN) | 1.05% | 0% | 31.08% | 1/12/2023 |
SpringWorks Therapeutics (SWTX) | 1.04% | 2.67% | 29.07% | - |
LabCorp (LH) | 1.03% | 0% | 31.08% | 1/12/2023 |
AstraZeneca (AZN) | 0.97% | 3.01% | 29.07% | - |
GlaxoSmithKline (GSK) | 0.96% | 0% | 31.08% | 1/12/2023 |
MannKind (MNKD) | 0.96% | 0% | 36.79% | 1/2/2024 |
Option Care Health (OPCH) | 0.92% | 3.23% | 29.07% | - |
Rocket (RCKT) | 0.88% | 2.44% | 29.07% | - |
Zai Lab (ZLAB) | 0.84% | 0% | 36.79% | 1/2/2024 |
Sorrento (SRNE) | 0.84% | 0% | 31.08% | 1/12/2023 |
BD (BDX) | 0.83% | 2.85% | 29.07% | - |
Arvinas (ARVN) | 0.83% | 2.8% | 29.07% | - |
Celldex (CLDX) | 0.8% | 0% | 36.79% | 1/2/2024 |
Inovio (INO) | 0.79% | 0% | 31.08% | 1/12/2023 |
TG Therapeutics (TGTX) | 0.75% | 3.67% | 22.52% | - |
Clovis Oncology Inc (CLVSQ) | 0.71% | 0% | 28.96% | 12/22/2022 |
Surface Oncology Inc (SURF) | 0.52% | 0% | 28.96% | 12/22/2022 |
Invitae Corp (NVTAQ) | 0.39% | 0% | 31.08% | 1/12/2023 |
Curis (CRIS) | 0.36% | 0% | 28.96% | 12/22/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2024
Instrument | Invested | Value |
---|---|---|
ImmunoGen Inc (IMGN) | 3.68% | 15.23% |
Bridgebio (BBIO) | 3.06% | 12.1% |
Blueprint Medicines (BPMC) | 3.06% | 4.67% |
Eli Lilly (LLY) | 2.12% | 3.92% |
Exelixis (EXEL) | 3.06% | 3.47% |
Mirati Therapeutics Inc (MRTX) | 5.07% | 3.4% |
Vertex (VRTX) | 2.42% | 3.36% |
Iovance (IOVA) | 3.06% | 3.18% |
CRISPR Therapeutics (CRSP) | 3.68% | 3.15% |
Regeneron (REGN) | 2.69% | 2.99% |
Exact Sciences (EXAS) | 3.68% | 2.77% |
Legend Biotech (LEGN) | 3.06% | 2.76% |
Amgen (AMGN) | 2.56% | 2.56% |
Revolution Medicines (RVMD) | 3.06% | 2.55% |
AbbVie (ABBV) | 2.95% | 2.43% |
Merck (MRK) | 2.11% | 2.34% |
Argenx (ARGX) | 3.06% | 2.3% |
Gilead Sciences (GILD) | 2.15% | 2.27% |
Johnson & Johnson (JNJ) | 2.88% | 2.16% |
Guardant Health (GH) | 5.07% | 2.12% |
Syndax (SNDX) | 3.06% | 2.01% |
Celldex (CLDX) | 3.06% | 2.01% |
MannKind (MNKD) | 3.06% | 1.77% |
BeiGene (BGNE) | 2.63% | 1.73% |
Bristol-Myers Squibb (BMY) | 2.93% | 1.72% |
Illumina (ILMN) | 4.56% | 1.7% |
Zai Lab (ZLAB) | 3.06% | 1.61% |
Fate Therapeutics (FATE) | 6.15% | 1.6% |
Pfizer (PFE) | 3.03% | 1.47% |